How to Prepare for a Regulatory Inspection: FDA, EMA, and Notified Body Audits

Charles H. Paul
Instructor: Charles H. Paul
Date: Wednesday April 30, 2025
Time:

10:00 AM PDT | 01:00 PM EDT

Duration: 60 Minutes
Webinar Id: 606457

Price Details

Live Webinar
$150. One Attendee
$290. Unlimited Attendees
Recorded Webinar
$190. One Attendee
$390. Unlimited Attendees
Combo Offers   (Live + Recorded)
$289 $340   One Attendee
$599 $680   Unlimited Attendees

Unlimited Attendees: Any number of participants

Recorded Version: Unlimited viewing for 6 months (Access information will be emailed 24 hours after the completion of live webinar)

Overview:

This 60-minute webinar provides a comprehensive guide on how to effectively prepare for regulatory inspections conducted by the FDA, EMA, and Notified Bodies.

It begins with an overview of the inspection processes and key focus areas for each regulatory authority, followed by practical strategies for pre-inspection preparation, including internal audits, staff training, and documentation readiness. Attendees will gain insights into best practices for managing inspections, from hosting auditors and handling document requests to responding to questions professionally. The session also covers post-inspection follow-up, including how to address findings, implement corrective actions, and ensure continuous compliance. With real-world insights and actionable strategies, this webinar equips life science professionals with the knowledge and confidence to navigate regulatory inspections successfully.

Why you should Attend:

Participants should take this training to gain a clear, practical understanding of regulatory inspections conducted by the FDA, EMA, and Notified Bodies, ensuring they are fully prepared to navigate these critical audits with confidence. Regulatory inspections can significantly impact a company’s compliance status, market approvals, and reputation, making thorough preparation essential.

This training provides valuable insights into common compliance pitfalls, best practices for pre-inspection readiness, and effective strategies for managing auditors and responding to findings. By attending, participants will learn how to strengthen internal audit processes, enhance documentation practices, and develop a proactive approach to regulatory compliance, ultimately reducing the risk of non-compliance and improving their organization’s inspection outcomes.

Areas Covered in the Session:

  • Introduction (5 minutes)
    • Welcome and speaker introduction
    • Overview of the importance of regulatory inspections
    • Key regulatory agencies: FDA, EMA, and Notified Bodies - roles and expectations
  • Understanding Regulatory Inspections (10 minutes)
    • FDA Inspections
      • Types (Routine, For-Cause, Pre-Approval, etc.)
      • Key focus areas
      • Inspection process and enforcement actions
    • EMA Inspections
      • GMP, GCP, and Pharmacovigilance inspections
      • Risk-based approach to inspections
      • Common observations
    • Notified Body Audits (EU MDR/IVDR)
      • Differences between regulatory inspections and NB audits
      • Audit frequency and scope
      • Trends in findings under EU MDR/IVDR
  • Pre-Inspection Preparation (15 minutes)
    • Internal audit and gap analysis
    • Training staff for regulatory inspections
    • Ensuring documentation readiness
      • Quality Management System (QMS)
      • Standard Operating Procedures (SOPs)
      • Compliance records and data integrity
    • Mock inspections and stress testing
  • Managing the Inspection Process (15 minutes)
    • Roles and responsibilities during an inspection
    • Hosting inspectors and managing site tours
    • Handling document requests and interviews
    • Communication best practices:
      • Do’s and Don’ts when interacting with inspectors/auditors
      • Responding to questions effectively
  • Post-Inspection Follow-Up (10 minutes)
    • Reviewing inspection observations
    • Preparing a Corrective and Preventive Action (CAPA) plan
    • Responding to Form 483, Warning Letters, and non-conformities
    • Continuous improvement and lessons learned

Who Will Benefit:

  • Quality Assurance (QA)
  • Regulatory Affairs
  • Compliance Officers
  • Manufacturing and Operations
  • Clinical and Pharmacovigilance Teams
  • Research and Development (R&D)
  • Quality Control (QC)
  • Supply Chain and Vendor Management
  • Auditors and Internal Compliance Teams
  • Senior Management and Executives in Life Sciences
  • Documentation and Technical Writing Teams
  • Training and Human Resources (HR) in Compliance-Related Roles

Speaker Profile
Charles H. Paul is the President of C. H. Paul Consulting, Inc. – a regulatory, manufacturing, training, and technical documentation consulting firm – celebrating its twentieth year in business in 2017. Charles has been a regulatory and management consultant and an Instructional Technologist for 30 years and has published numerous white papers on various regulatory and training subjects. The firm works with both domestic and international clients designing solutions for complex training and documentation issues.

He has held senior positions in consulting and in corporate training development prior to forming C. H. Paul Consulting, Inc.. He also worked for several years in government contracting managing the development of significant Army-wide training development contracts impacting virtually all of the active Army and changing the training paradigm throughout the military.

He has dedicated his entire professional career explaining the benefits of performance-based training

Sign Up for Our Newsletter